AFMD 241220 2.50P (AFMD241220P2500) Stock Options, News & Quotes

0.25
0.000.00%

15min DelayTrading Nov 22 15:55 ET

0.00High0.00Low

SymbolStock Name

Latest PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

Jaguar8

Nov 5 08:01

NEWS

$Affimed NV (AFMD.US)$
Affimed Announces Acceptance of Three Abstracts at the 2024 ASH Annual Meeting Including an Oral Presentation Underscoring Advancing Clinical Pipeline in Leukemia and Lymphoma

Trytosaveabit

Sep 5 05:33

Make a note of possible upcoming catalysts.

$Affimed NV (AFMD.US)$ Upcoming Milestones:
-- LuminICE-203: Efficacy update of cohorts 1-4 expected to be presented at
a future scientific conference in Q4 2024.
-- AFM24-102: ORR and safety data from the EGFRwt cohort in Q4 2024.
-- AFM28-101: Data from the study is expected to be presented at a
scientific conference in Q4 2024.
-- AMF24-102: Mature PFS data from EGFRmut and EGFRwt cohorts expected to be
presented at a future conference in H1...

Goodjobguys

Aug 1 09:43

7 Cheap But Risky Biotech Stocks? Funds moving from big corporations to Small Caps?

$Immuneering (IMRX.US)$ $SPDR S&P Biotech ETF (XBI.US)$ $iShares Biotechnology ETF (IBB.US)$ $S&P 500 Index (.SPX.US)$ $BioAtla (BCAB.US)$ $Gilead Sciences (GILD.US)$ $Affimed NV (AFMD.US)$ $Instil Bio (TIL.US)$ $Nkarta (NKTX.US)$
Biotech stocks remain depressed, nearly two years into a dip that has seen the SPDR S&P Biotech ETF XBI 0.05% drop nearly 50%.
The other most-watched exchange-traded fund that tracks the biotech secto...

Trytosaveabit

Jun 12 07:05

For you notes!

$Affimed NV (AFMD.US)$ Upcoming Milestones: • Data readout from the 12 patients in cohorts 1 and 2 of the LuminICE-203 (AFM13 combination with AlloNK® cells) study in Q3 2024.
• ORR and PFS data from the 25 patients in the EGFRmut cohort of the AFM24-102 study in Q3 2024.
• ORR and PFS data from the 40 patients in the EGFRwt cohort of the AFM24-102 study in Q4 2024.

NinjaTradez

Jun 3 21:42

Tradershub.ninja

$Avalon GloboCare (ALBT.US)$ $Affimed NV (AFMD.US)$ $Structure Therapeutics (GPCR.US)$ $Finch Therapeutics (FNCH.US)$
On fire